Intellia Therapeutics
NTLA
NTLA
292 hedge funds and large institutions have $1.16B invested in Intellia Therapeutics in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 127 increasing their positions, 68 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 283 → 292 (+9)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
40% less capital invested
Capital invested by funds: $1.92B → $1.16B (-$757M)
Holders
292
Holding in Top 10
2
Calls
$16.5M
Puts
$11.5M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$23.5M | |
| 3 | +$22.8M | |
| 4 |
Morgan Stanley
New York
|
+$19.3M |
| 5 |
BlackRock
New York
|
+$16.9M |
Top Sellers
| 1 | -$102M | |
| 2 | -$42.7M | |
| 3 | -$30.1M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$28.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17M |